International trade · 05/01/1995Updated: 10/18/2026 · 1 min read
U.S. International Trade Commission Denies Review of Genentech's Patent Claim Withdrawal
Summary
The U.S. International Trade Commission has decided not to review the initial determination granting Genentech, Inc. permission to withdraw a patent claim from an ongoing investigation into recombinantly produced human growth hormones.
Original source language: Federal Register — International Trade CommissionOpen original release →